'Maximising Opportunities for Life Sciences
Kindly supported and hosted by
There is no doubt that the UK’s departure from the EU will provide both opportunities and challenges in many areas of an organisations’ operation. In regards to life sciences, this will be most keenly seen in areas such as access to funding, talent, movement of goods, regulatory activity and clinical trials.
This edition of our Senior Executive Breakfast events will feature three experts from the fields of funding, regulatory and legal, who will provide an update and be available for round table questions on where the new opportunities are for the industry, and how companies’ leaders can ensure they are making the most of them.
08:30 Registration, Breakfast & Networking
09:00 Welcome & Introductions by OBN
09:05 Introduction by Oliver Pumfrey, Managing Director, FTI Consulting
09:10 Keynote: Ian King, Deputy Director, EU & International, Policy Division at the MHRA. An update on the MRHA’s post Brexit regulatory framework, including what it means for life sciences innovation and how it will accelerate research and ultimately benefit patients
09.30 Keynote: James Tumbridge, Partner, Barrister - Venner Shipley. An update on how changes in IP legislation bureaucracy post Brexit can create opportunities for the industry
09.50 Keynote: Shawn Manning, Managing Director, Akesios Associates. An update on the Life Sciences funding landscape post Brexit. What changes might we expect and what will be the likely impact to the existing UK ecosystem?
10.10 Round table Q&A
10:30 Event close